These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 34232888)
1. Systems Medicine Design based on Systems Biology Approaches and Deep Neural Network for Gastric Cancer. Yeh SJ; Chen BS IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(5):3019-3031. PubMed ID: 34232888 [TBL] [Abstract][Full Text] [Related]
2. Identifying Drug Targets of Oral Squamous Cell Carcinoma through a Systems Biology Method and Genome-Wide Microarray Data for Drug Discovery by Deep Learning and Drug Design Specifications. Lin YC; Chen BS Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142321 [TBL] [Abstract][Full Text] [Related]
3. Multiple-Molecule Drug Design Based on Systems Biology Approaches and Deep Neural Network to Mitigate Human Skin Aging. Yeh SJ; Lin JF; Chen BS Molecules; 2021 May; 26(11):. PubMed ID: 34073305 [TBL] [Abstract][Full Text] [Related]
4. Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms. Yeh SJ; Hsu BJ; Chen BS Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802957 [TBL] [Abstract][Full Text] [Related]
5. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer. Yeh SJ; Lin CY; Li CW; Chen BS Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126066 [TBL] [Abstract][Full Text] [Related]
6. Systems Approach to Pathogenic Mechanism of Type 2 Diabetes and Drug Discovery Design Based on Deep Learning and Drug Design Specifications. Chang S; Chen JY; Chuang YJ; Chen BS Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375269 [TBL] [Abstract][Full Text] [Related]
7. Drug Target Identification and Drug Repurposing in Psoriasis through Systems Biology Approach, DNN-Based DTI Model and Genome-Wide Microarray Data. Zhan YP; Chen BS Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373186 [TBL] [Abstract][Full Text] [Related]
8. Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. Su PW; Chen BS Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430344 [TBL] [Abstract][Full Text] [Related]
9. Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug-Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis. Chou SP; Chuang YJ; Chen BS Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409019 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer. Yeh SJ; Chen SW; Chen BS Front Genet; 2020; 11():117. PubMed ID: 32211020 [TBL] [Abstract][Full Text] [Related]
11. Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method. Yeh SJ; Yeh TY; Chen BS Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743172 [TBL] [Abstract][Full Text] [Related]
12. Investigating Core Signaling Pathways of Hepatitis B Virus Pathogenesis for Biomarkers Identification and Drug Discovery via Systems Biology and Deep Learning Method. Chang S; Wang LH; Chen BS Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32878239 [TBL] [Abstract][Full Text] [Related]
13. Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. Yeh SJ; Chang CA; Li CW; Wang LH; Chen BS Oncotarget; 2019 Jun; 10(38):3760-3806. PubMed ID: 31217907 [TBL] [Abstract][Full Text] [Related]
14. Investigating Common Pathogenic Mechanisms between Yeh SJ; Yeh CC; Lan CY; Chen BS Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30769958 [No Abstract] [Full Text] [Related]
15. Investigation mechanisms between normal, developing and regenerating livers for regenerative liver drug design. Wong SW; Yeh SJ; Li CW; Wang LH; Chen BS Regen Med; 2019 May; 14(5):359-387. PubMed ID: 31204905 [No Abstract] [Full Text] [Related]
16. Constructing an integrated genetic and epigenetic cellular network for whole cellular mechanism using high-throughput next-generation sequencing data. Chen BS; Li CW BMC Syst Biol; 2016 Feb; 10():18. PubMed ID: 26897165 [TBL] [Abstract][Full Text] [Related]
17. Genetic and Epigenetic Host-Virus Network to Investigate Pathogenesis and Identify Biomarkers for Drug Repurposing of Human Respiratory Syncytial Virus via Real-World Two-Side RNA-Seq Data: Systems Biology and Deep-Learning Approach. Hsu BW; Chen BS Biomedicines; 2023 May; 11(6):. PubMed ID: 37371627 [TBL] [Abstract][Full Text] [Related]
18. Investigating core genetic-and-epigenetic cell cycle networks for stemness and carcinogenic mechanisms, and cancer drug design using big database mining and genome-wide next-generation sequencing data. Li CW; Chen BS Cell Cycle; 2016 Oct; 15(19):2593-2607. PubMed ID: 27295129 [TBL] [Abstract][Full Text] [Related]
19. Investigating Pathogenetic Mechanisms of Alzheimer's Disease by Systems Biology Approaches for Drug Discovery. Yeh SJ; Chung MH; Chen BS Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681938 [TBL] [Abstract][Full Text] [Related]
20. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer. Song WM; Lin X; Liao X; Hu D; Lin J; Sarpel U; Ye Y; Feferman Y; Labow DM; Walsh MJ; Zheng X; Zhang B Int J Cancer; 2020 Mar; 146(5):1268-1280. PubMed ID: 31463974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]